Oxygenta Pharmaceutical standalone net profit declines 92.41% in the December 2021 quarter
Sales decline 45.22% to Rs 15.93 crore
Net profit of Oxygenta Pharmaceutical declined 92.41% to Rs 0.22 crore in the quarter ended December 2021 as against Rs 2.90 crore during the previous quarter ended December 2020. Sales declined 45.22% to Rs 15.93 crore in the quarter ended December 2021 as against Rs 29.08 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales15.9329.08 -45 OPM %5.2711.55 -PBDT0.623.17 -80 PBT0.222.90 -92 NP0.222.90 -92Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 14 2022 | 4:57 PM IST